acquisit propel health
strengthen posit copd
agre acquir propel health propel health
leader chronic obstruct pulmonari diseas copd asthma connect
health solut believ transact make strateg sens enabl
get involv end patient earlier stage assist
grow share copd market strengthen relationship
pharmaceut compani propel health current loss-mak
expect quickli becom protabl cost subsid retain
buy recommend given level tsr
acquisit give earli access copd patient
expect abl increas copd market share
access patient earlier stage transit patient
product progress later copd stage estim
share copd ventil portabl oxygen concentr market
therefor larg potenti increas market share
transact ep dilut
revis forecast acquisit propel health
assum propel health continu loss-mak
howev assum propel health abl gener sucient return
cover cost associ acquisit debt fund onward
revis tp vs prev deriv use dcf valuat
methodolog dcf use wacc coe d/ev
downsid risk includ advers chang reimburs new competitor
forecast ratio
price dec
distribut gmt
deutsch bank seek busi compani cover research report thu investor
awar rm may conict interest could aect object report investor consid
report singl factor make invest decis disclosur analyst certif
revis forecast acquisit propel health
assum propel health continu loss-mak
howev assum propel health abl gener sucient return
cover cost associ acquisit debt fund onward
long-term assumpt propel health gener return
cover associ acquisit fund probabl conserv compar
manag expect busi howev given minim amount
nancial inform disclos propel health copd sale
reluct make signic chang long-term forecast
manag said provid updat acquir
develop plan busi
point
db view transact believ transact make strateg
sens enabl get involv end patient
earlier stage assist grow share copd
market strengthen relationship pharmaceut compani
custom propel health
transact overview agre acquir propel health
propel health leader chronic obstruct pulmonari
diseas copd asthma connect health solut
rational transact synergi
propel health oper stand-alone busi
immedi chang manag locat busi
process therefor anticip cost synergi
propel product use copd stage ii
complement ventil portabl oxygen concentr
use stage iv expect
abl increas market share access
patient earlier stage transit patient
product progress later copd stage base
manag comment estim share
copd ventil portabl oxygen concentr market
therefor see larg potenti increas share
market
figur share copd poc ventil market
propel health sell servic pharmaceut custom
believ transact allow relationship
develop pharmaceut compani believ
import develop telemonitor oer
integr health ecosystem
understand propel health predominantli us busi
expect use global presenc expand propel
revenu new geographi
global copd suffer use poc ventil global poc/ventil revenu share share decemb
transact fund manag said acquisit
fund primarili credit facil transact forecast
leverag ratio increas vs prev
gear ratio increas vs prev
financi transact metric nancial
disclos manag said propel health small level
revenu current loss-mak due expenditur
establish custom relationship transact multipl
ev/ebitda ev/ebit meaning
ep dilut manag expect transact dilut
impact non-gaap ep rang per quarter
calcul post-tax debt fund equat
therefor impli propel health busi current lose
npat per quarter propel health move
develop phase expect quickli becom protabl
time manag expect nalis deal end
propellor found privat fund compani
propellor leader chronic obstruct pulmonari diseas copd
asthma connect health solut help peopl doctor better
manag copd asthma
propel digit medicin platform consist small sensor attach
consum inhal pair mobil app automat track medic
use provid person feedback insight
propel clinic valid solut demonstr improv
medic adher increas symptom-fre day
reduct emerg room visit
propellor market share custom relationship
multipl pharmaceut compani two competitor
singl custom relationship pharmaceut compani
propellor current loss-mak due expenditur
target price prev base
dcf valuat use three-stag dcf model discount post-tax free cash
ow reduc target price due inclus propel
acquisit minim earn contribut outer year forecast
wacc assum beta coe risk-fre rate
assum long-term govern bond rate standard market risk premium
target d/ev forecast explicit cash ow follow
horizon period cash ow growth fade long-term
termin valu growth rate set termin growth rate
slight premium nomin global estim reect long-term
demand trend rmd osa product
signic reduct product fund reimburs
new innov product releas competitor lead market
elev price pressur increas competit
price current end previou trade session unless otherwis indic sourc local exchang via reuter bloomberg vendor
inform sourc deutsch bank subject compani sourc disclosur pertain recommend estim made secur
primari subject research pleas see recent publish compani report visit global disclosur look-up page websit http //research db com/
research/disclosures/companysearch asid within report import risk conict disclosur also found http //research db com/research/topics/equ
investor strongli encourag review inform invest
import disclosur requir regul
